Biogen Q2 revenue, adjusted EPS beat estimates as growth portfolio lifts sales
Go back to Biogen Q2 revenue, adjusted EPS beat estimates as growth portfolio lifts sales| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 220.83 -3.68 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.51 | 52 Week High | $333.65 | |||
| Open | $221.15 | 52 Week Low | $223.02 | |||
| Day High | $223.82 | P/E | 28.28 | |||
| Day Low | $219.82 | EPS | $7.81 | |||
| Volume | 465,108 | |||||
